176 related articles for article (PubMed ID: 5670163)
1. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
Laubinger G
Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
[No Abstract] [Full Text] [Related]
2. [Action mechanism and clinical success of Regelan (Clofibrate)].
Fitzgerald JD
Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
[No Abstract] [Full Text] [Related]
3. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
Bertulla A; Bertamino V; Solari E
Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
[No Abstract] [Full Text] [Related]
4. Clofibrate and androsterone effect on serum lipids.
Orgain ES; Bogdonoff MD; Cain C
Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
[No Abstract] [Full Text] [Related]
5. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
6. [Hyperlipidemias: occurrence, significance, therapy].
Knüchel F
Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
[No Abstract] [Full Text] [Related]
7. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
Cloarec M; Cottet J; Etienne J; Loeper J
Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
[No Abstract] [Full Text] [Related]
8. Atromid-S for the reduction of plasma lipids.
Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
[No Abstract] [Full Text] [Related]
9. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
De Michelis S; Paparella P; Seu V
Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
[No Abstract] [Full Text] [Related]
10. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
[No Abstract] [Full Text] [Related]
11. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
12. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
Duncan GG; Elliott FA; Duncan TG; Schatanoff J
Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
[No Abstract] [Full Text] [Related]
13. [Drug therapy of dyslipidemias].
Fonda M; Cattin L; Guarnieri G
Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
[No Abstract] [Full Text] [Related]
14. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
Oliver MF
Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
[No Abstract] [Full Text] [Related]
15. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
[No Abstract] [Full Text] [Related]
16. [Atherosclerosis and Regelan].
Schwaar R
Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569
[No Abstract] [Full Text] [Related]
17. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
Hammerl H; Kränzl C; Pichler O; Studlar M
Med Welt; 1969 Aug; 31():1715-7. PubMed ID: 4895455
[No Abstract] [Full Text] [Related]
18. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
[No Abstract] [Full Text] [Related]
19. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
Horlick L; Kudchodkar BJ; Sodhi HS
Circulation; 1971 Feb; 43(2):299-309. PubMed ID: 5540713
[No Abstract] [Full Text] [Related]
20. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
Ferri F; Regazzini A; Pedini G
G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
[No Abstract] [Full Text] [Related]
[Next] [New Search]